Latest News and Press Releases

Ce partenariat permet d'associer la technologie OligoCreator® de Secarna avec la plateforme VECTrans® de Vect-Horus, afin de rendre possible le transport systémique des oligonucléotides à travers la...

The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable systemic delivery of oligonucleotide therapies across the blood-brain barrierThis...

London based tech innovator Blackbird plc raises £2m to scale elevate.io, the figma for video.

DALLAS, July 01, 2025 (GLOBE NEWSWIRE) -- BioNTX, the premier trade organization for biotechnology and healthcare innovation in North Texas, is proud to announce the expansion of its 4th annual Tech...

FRANKFURT, Germany, June 24, 2025 (GLOBE NEWSWIRE) -- The China-Germany Standardization Cooperation Innovation Center was officially inaugurated in Frankfurt on June 23. The opening ceremony, held...

A rare SaaS platform whose global growth is driven by product adoption and customer revenue — not venture capital.

KUALA LUMPUR, MALAYSIA, June 18, 2025 (GLOBE NEWSWIRE) -- TMD Energy Limited (the “Company” or “TMDEL”) (NYSE American: TMDE), together with its subsidiaries is a Malaysia and Singapore based...

台灣, June 06, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技（以下簡稱「浩鼎」）（4174.TWO）今（06/06）宣布，與美國TegMine Therapeutics, Inc.（以下簡稱「TegMine」）簽署ADC研發服務合約（Master Services Agreement, MSA）；TegMine...

台湾, June 06, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技（以下简称「浩鼎」）（4174.TWO）今（06/06）宣布，与美国TegMine Therapeutics, Inc.（以下简称「TegMine」）签署ADC研发服务合约（Master Services Agreement, MSA）；TegMine...

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug...